RALEIGH — At the request of legislators, the UNC Health Care system is shedding more light on its relationship with Raleigh-based Rex Healthcare, which it has owned since 2000.
Pressured by a legislative committee to be fully transparent with the system’s finances, Bill Roper, UNC Health Care CEO and dean of the UNC School of Medicine, has requested an audit of its Enterprise Fund.
The system uses the Enterprise Fund to transfer money between its various entities, including Rex. Contributions to and expenditures from the Enterprise Fund have been audited, but the state auditor has never undertaken a full examination of the fund.
“They continue to have questions, and we’ve given them all sorts of information about the Enterprise Fund,” said Karen McCall, spokeswoman for UNC Health Care. “It would help everybody to say that the Enterprise Fund itself has been audited.”
The system’s financial interactions with Rex have been under scrutiny since Raleigh-based WakeMed Health & Hospitals submitted a $750 million bid to buy Rex from UNC Health Care in May. The system’s board of directors rejected the bid in August.
The General Assembly has held hearings since then to consider selling Rex without the system’s consent due to the potential financial benefits of such a large sale.
UNC Health Care released Tuesday six pages of answers to questions posed by the N.C. House of Representatives’ Select Committee on State-Owned Assets.
The papers showed that Rex had a net operating margin of $34.6 million for fiscal year 2010, most of which was reinvested in the hospital. During the last 10 years, Rex has transferred $20 million to UNC Health Care.
UNC